| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |